Moolec Science ( NASDAQ:MLEC – Get Free Report ) is one of 673 public companies in the “Holding & other investment offices” industry, but how does it compare to its rivals? We will compare Moolec Science to similar companies based on the strength of its dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings. Profitability This table compares Moolec Science and its rivals’ net margins, return on equity and return on assets. Earnings and Valuation This table compares Moolec Science and its rivals top-line revenue, earnings per share and valuation.
Risk & Volatility Moolec Science has a beta of -0.54, suggesting that its share price is 154% less volatile than the S&P 500. Comparatively, Moolec Science’s rivals have a beta of 0.
03, suggesting that their average share price is 97% less volatile than the S&P 500. Analyst Recommendations This is a breakdown of recent ratings for Moolec Science and its rivals, as provided by MarketBeat.com.
Moolec Science presently has a consensus target price of $6.00, suggesting a potential upside of 582.52%.
As a group, “Holding & other investment offices” companies have a potential upside of 51.27%. Given Moolec Science’s stronger consensus rating and higher probable upside, research analysts plainly believe Moolec Science is more favorable than its rivals.
Insider & Institutional Ownership 0.1% of Moolec Science shares are held by institutional investors. Comparatively, 54.
2% of shares of all “Holding & other investment offices” companies are held by institutional investors. 19.9% of Moolec Science shares are held by insiders.
Comparatively, 26.7% of shares of all “Holding & other investment offices” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary Moolec Science rivals beat Moolec Science on 10 of the 13 factors compared. About Moolec Science ( Get Free Report ) Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product.
It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg. Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.
com's FREE daily email newsletter ..
Business
Head to Head Review: Moolec Science (MLEC) vs. Its Rivals
Moolec Science (NASDAQ:MLEC – Get Free Report) is one of 673 public companies in the “Holding & other investment offices” industry, but how does it compare to its rivals? We will compare Moolec Science to similar companies based on the strength of its dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings. Profitability This [...]